Approaching Pancytopenia

Similar documents
Introduction. About 10,500 new cases of acute myelogenous leukemia are diagnosed each

Cord blood Banking Transplant List for One USA Bank - StemCyte

Corporate Medical Policy Genetic Testing for Fanconi Anemia

ACUTE MYELOID LEUKEMIA (AML),

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.

Malignant Lymphomas and Plasma Cell Myeloma

LYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons

Laboratory Studies in the Diagnosis of Iron Deficiency, Latent Iron Deficiency and Iron Deficient Erythropoiesis

Cord Cor Blood Banking Scott N. Furlan, MD Ellen S. Plummer, Plummer MD


BONE MARROW FAILURE DISEASE SYMPOSIUM SATURDAY SEPTEMBER 27, 2014 AN UPDATE ON THE LATEST IN DIAGNOSIS AND TREATMENT

Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology

Stem Cell Transplantation

An overview of CLL care and treatment. Dr Dean Smith Haematology Consultant City Hospital Nottingham

STEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA

Acute myeloid leukemia (AML)

Chronic Lymphocytic Leukemia. Case Study. AAIM Triennial October 2012 Susan Sokoloski, M.D.

Acute Myeloid Leukemia

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Pre- Transformed Ig Surface Surface Secreted Myeloma Major malignant counterpart

GRANIX (tbo-filgrastim)

Talking With Your Doctor About Multiple Myeloma: A guide to making the most of your healthcare visits

Brain Cancer. This reference summary will help you understand how brain tumors are diagnosed and what options are available to treat them.

Evaluation of a Child with Elevated Transaminases. Linda V. Muir, M.D. April 11, 2008 Northwest Pediatric Liver Disease Symposium

Technical University of Mombasa Faculty of Applied and Health Sciences

Cytogenetics for the Rest of Us: A Primer

Things You Don t Want to Miss in Multiple Myeloma

Pathology No: SHS-CASE No. Date of Procedure: Client Name Address

Why discuss CLL? Common: 40% of US leukaemia. approx 100 pa in SJH / MWHB 3 inpatients in SJH at any time

Young fetus: site of hematopoiesis together with the liver and bone marrow. Hgb WBC > < Plt Hct. Retic =

Careers in Haematology

HAEMATOLOGY LABORATORY

Interesting Case Series. Periorbital Richter Syndrome

MULTIPLE MYELOMA Review & Update for Primary Care. Dr. Joseph Mignone 21st Century Oncology

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL VOLUME I RESPONSE ASSESSMENT LEUKEMIA CHAPTER 11A REVISED: OCTOBER 2015

MEDICAL COVERAGE POLICY

IRON METABOLISM DISORDERS

Not All Stem Cells are the Same

NATIONAL CANCER INSTITUTE. Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma

What is a Stem Cell Transplantation?

Diseases Treated by Blood Stem Cells

Adult Medical-Surgical Nursing H A E M A T O L O G Y M O D U L E : L E U K A E M I A 2

Estimated New Cases of Leukemia, Lymphoma, Myeloma 2014

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia

亞 東 紀 念 醫 院 Follicular Lymphoma 臨 床 指 引

Interesting Case Review. Renuka Agrawal, MD Dept. of Pathology City of Hope National Medical Center Duarte, CA

Bone Marrow Evaluation for Lymphoma. Faizi Ali, MD Hematopathology Fellow William Beaumont Hospital

Childhood Cancer in the Primary Care Setting

PROTOCOLS FOR TREATMENT OF MALIGNANT LYMPHOMA

Waldenström Macroglobulinemia: The Burning Questions. IWMF Ed Forum May Morie Gertz MD, MACP

Preoperative Laboratory and Diagnostic Studies

FastTest. You ve read the book now test yourself

Oncology Best Practice Documentation

NEW YORK STATE CYTOHEMATOLOGY PROFICIENCY TESTING PROGRAM Glass Slide Critique ~ November 2010

My Sister s s Keeper. Science Background Talk

Stem Cell Transplantation In Patients with Fanconi Anemia

Multiple Myeloma. This reference summary will help you understand multiple myeloma and its treatment options.

Leukemias and Lymphomas: A primer

Subtypes of AML follow branches of myeloid development, making the FAB classificaoon relaovely simple to understand.

LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials

COLONIAL LIFE & ACCIDENT INSURANCE COMPANY P.O. Box 1365, Columbia, South Carolina

Mean Platelet Volume (MPV) in Thrombocytopenia

CHAPTER 2. Neoplasms (C00-D49) March MVP Health Care, Inc.

Summary of the risk management plan (RMP) for Accofil (filgrastim)

Canadian Blood Services National Public Cord Blood Bank Give Life Twice Transfusion Medicine Residents

Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood

Elevated Serum Lactate Dehydrogenase Values in Children with Multiorgan Involvements and Severe Febrile Illness

Cord Blood Stem Cell Transplantation

An Introduction to the Improved FDA Prescription Drug Labeling

Stem Cell Transplantation and the Canadian First Nations Community. Becky Luk (PTLS) Tanya Petraszko, MD

PT CordLife Indonesia Premium Cordblood Bank. PT CordLife Indonesia Premium Cordblood Bank

2011 Update on the ECIL-3 guidelines for EBV management in patients with leukemia and other hematological disorders

APPENDIX B SAMPLE INFORMED CONSENT FORM

What we will discuss today

Cancer 1000 Level 2 Benefit Chart and Outline of Coverage

General Rules SEER Summary Stage Objectives. What is Staging? 5/8/2014

Emerging New Prognostic Scoring Systems in Myelodysplastic Syndromes 2012


ICD-10 CM/PCS Tip Sheets. Oncology

Easy Bruising and Bleeding in the Adult Patient: A Sign of Underlying Disease

PLATELETS: OVERVIEW. J. Kelton, M.D. May 3 rd, 2003

Role of Transfusion Medicine Consultant in Peripheral Blood Stem Cell Transplant Program

Oncology. Objectives. Cancer Nomenclature. Cancer is a disease of the cell Cancer develops when certain cells begin to grow out of control

COLONIAL LIFE & ACCIDENT INSURANCE COMPANY P.O. Box 1365, Columbia, South Carolina

Lung Cancer. This reference summary will help you better understand lung cancer and the treatment options that are available.

Proteins. Protein Trivia. Optimizing electrophoresis

LCD for Viral Hepatitis Serology Tests

Multiple Myeloma Patient s Booklet

Interpretation of Laboratory Values

Chapter 4 Section High Dose Chemotherapy (HDC) And Stem Cell Transplantation

Transcription:

Approaching Pancytopenia Lisa Sproat MD, MSW American College of Osteopathic Internists Annual Convention 2013 2012 MFMER slide-1

Objectives Understand work up of Pancytopenia Present differential diagnosis of Pancytopenia Recognize Not Miss causes of Pancytopenia 2012 MFMER slide-2

2012 MFMER slide-3

Most common indication for bone marrow biopsy 2012 MFMER slide-4

H&P Fever URI symptoms LAD Hepato or splenomegaly B symptoms Travel history Prescribed, non-prescribed and herbal medications ETOH Environmental and chemical exposure history Sexual history 2012 MFMER slide-5

Most Common Cause Chemotherapy 2012 MFMER slide-6

Congenital Bone Marrow Failure Syndromes Fanconi Anemia (Mitomycin C or Diepoxybutane test) Dyskeratosis Congenita (genetic testing) Shwachman-Diamond Syndrome (genetic testing, sweat chloride test normal) Congenital Amegakaryocytic Thrombocytopenia (genetic testing, elevated thrombopoietin level) Hemophagocytic Lymphohistiocytosis (hemophagocytosis, hypertriglyceridemia, hypofibrinogenemia, low/absent NK cell activity, elevated serum ferritin, soluble CD25>2,400 U/ml 2012 MFMER slide-7

Paroxysmal Nocturnal Hemoglobinuria Hemolysis Pancytopenia Venous Thrombosis Flow Cytometry for PNH: CD CD55 and 59 2012 MFMER slide-8

Peripheral Destruction of Hematopoietic Cells Hemophagocytosis Prosthetic valves Splenomegaly Drugs Infection 2012 MFMER slide-9

Sequestration Splenomegaly 2012 MFMER slide-10

Acquired Bone Marrow Failure Syndromes Most often what is seen in adult population 2012 MFMER slide-11

Chemotherapy 2012 MFMER slide-12

Radiation 2012 MFMER slide-13

Autoimmune Disorders Aplastic Anemia Idiopathic (if not caused by drugs, chemicals,radiation,virus, anorexia, pregnancy) Distinguish from hypoplastic MDS (cytogenetics and FISH) 2012 MFMER slide-14

The Differential Diagnosis and Bone Marrow Evaluation of New-Onset Pancytopenia Elizabeth P. Weinzierl, MD, PhD and Daniel A. Arber, MD American Journal of Clinical Pathology, 2013; 139, 9-29. 2012 MFMER slide-15

Autoimmune Disorders Systemic Lupus Erythematosus Any other autoimmune disorder (or the treatment for it) 2012 MFMER slide-16

Marrow Space Occupying Lesions Heme malignancy MDS/MPD Leukemia Lymphoma Multiple Myeloma Metastatic malignancy Granulomatous disease 2012 MFMER slide-17

Infection Viral Fungal Bacterial 2012 MFMER slide-18

The Differential Diagnosis and Bone Marrow Evaluation of New-Onset Pancytopenia Elizabeth P. Weinzierl, MD, PhD and Daniel A. Arber, MD American Journal of Clinical Pathology, 2013; 139, 9-29. 2012 MFMER slide-19

Hemophagocytosis Must have 5 of the following Fever Splenomegaly Cytopenia involving 2 or more cell lines Hypertriglyceridemia or hypofibrinogenemia Hepatitis Low or absent NK cell activity Histiocyte activation 2012 MFMER slide-20

Ineffective Marrow Production Drugs ETOH Infiltration Deficiencies 2012 MFMER slide-21

Malignancy Any Lung and Breast most common non heme malignancy 2012 MFMER slide-22

Drugs Most common cause for aplastic anemia 2012 MFMER slide-23

The Differential Diagnosis and Bone Marrow Evaluation of New-Onset Pancytopenia Elizabeth P. Weinzierl, MD, PhD and Daniel A. Arber, MD American Journal of Clinical Pathology, 2013; 139, 9-29. Shimamura A, Guinan E. Acquired and inherited aplastic anemia syndromes. In: Greer J, Foerster J, Lukens Jet al. Wintrobe s Clinical Hematology. 11th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004 2012 MFMER slide-24

Nutritional Deficiencies Copper Folate B12 Anorexia Nervosa 2012 MFMER slide-25

The Differential Diagnosis and Bone Marrow Evaluation of New-Onset Pancytopenia Elizabeth P. Weinzierl, MD, PhD and Daniel A. Arber, MD American Journal of Clinical Pathology, 2013; 139, 9-29. 2012 MFMER slide-26

The Differential Diagnosis and Bone Marrow Evaluation of New-Onset Pancytopenia Elizabeth P. Weinzierl, MD, PhD and Daniel A. Arber, MD American Journal of Clinical Pathology, 2013; 139, 9-29. 2012 MFMER slide-27

Work up H&P Fever URI symptoms LAD Hepato or splenomegaly B symptoms Travel history Prescribed, non-prescribed and herbal medications ETOH Environmental and chemical exposure history Sexual history CBC Diff MCV Review of peripheral smear blasts Bone Marrow Biopsy Aspirate and Core Flow Cytometry Cytogenetics FISH PCR *Talk to your pathologist 2012 MFMER slide-28

Not Miss MDS Distinguish from AA Leukemia Early treatment has better outcomes for the non elderly population HIV I have been fooled! ETOH I have been fooled! 2012 MFMER slide-29

Take Home Points H and P will lead you Listen to your patients but check for HIV and watch for ETOH withdrawal Don t miss Leukemia (AML or ALL) Bone Marrow Biopsy Talk to the pathologist 2012 MFMER slide-30

Thank You!!!! Lisa Sproat MD, MSW sproat.lisa@mayo.edu 2012 MFMER slide-31